145 related articles for article (PubMed ID: 37977354)
1. Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment.
Fang Z; Jiang J; Zheng X
Life Sci; 2023 Dec; 335():122276. PubMed ID: 37977354
[TBL] [Abstract][Full Text] [Related]
2. PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis.
Powers NE; Swartzwelter B; Marchetti C; de Graaf DM; Lerchner A; Schlapschy M; Datar R; Binder U; Edwards CK; Skerra A; Dinarello CA
J Biol Chem; 2020 Jan; 295(3):868-882. PubMed ID: 31819009
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury.
Lindblad C; Rostami E; Helmy A
Neurotherapeutics; 2023 Oct; 20(6):1508-1528. PubMed ID: 37610701
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis.
Volarevic V; Al-Qahtani A; Arsenijevic N; Pajovic S; Lukic ML
Autoimmunity; 2010 Jun; 43(4):255-63. PubMed ID: 19845478
[TBL] [Abstract][Full Text] [Related]
5. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
[TBL] [Abstract][Full Text] [Related]
6. Injectable biomaterials for delivery of interleukin-1 receptor antagonist: Toward improving its therapeutic effect.
Clements AEB; Murphy WL
Acta Biomater; 2019 Jul; 93():123-134. PubMed ID: 31029831
[TBL] [Abstract][Full Text] [Related]
7. Why not treat human cancer with interleukin-1 blockade?
Dinarello CA
Cancer Metastasis Rev; 2010 Jun; 29(2):317-29. PubMed ID: 20422276
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo.
Klueh U; Antar O; Qiao Y; Kreutzer DL
J Diabetes Sci Technol; 2013 Nov; 7(6):1538-46. PubMed ID: 24351180
[TBL] [Abstract][Full Text] [Related]
10. [DIRA: life-threatening but treatable inherited inflammatory disease].
ter Haar NM; van Royen A; van Gijn ME; Frenkel J
Ned Tijdschr Geneeskd; 2010; 154():A1601. PubMed ID: 20482912
[TBL] [Abstract][Full Text] [Related]
11. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
[TBL] [Abstract][Full Text] [Related]
12. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
[TBL] [Abstract][Full Text] [Related]
13. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
Kalliolias GD; Liossis SN
Expert Opin Investig Drugs; 2008 Mar; 17(3):349-59. PubMed ID: 18321234
[TBL] [Abstract][Full Text] [Related]
14. IL-1β receptor antagonist reduces inflammation in hemodialysis patients.
Hung AM; Ellis CD; Shintani A; Booker C; Ikizler TA
J Am Soc Nephrol; 2011 Mar; 22(3):437-42. PubMed ID: 21310819
[TBL] [Abstract][Full Text] [Related]
15. Treating inflammation by blocking interleukin-1 in humans.
Dinarello CA; van der Meer JW
Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 receptor antagonist.
Lennard AC
Crit Rev Immunol; 1995; 15(1):77-105. PubMed ID: 8519423
[TBL] [Abstract][Full Text] [Related]
17. IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.
Gorelik M; Lee Y; Abe M; Andrews T; Davis L; Patterson J; Chen S; Crother TR; Aune GJ; Noval Rivas M; Arditi M
Clin Exp Immunol; 2019 Oct; 198(1):101-110. PubMed ID: 31099056
[TBL] [Abstract][Full Text] [Related]
18. Anakinra Pilot - a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants.
Green EA; Metz D; Galinsky R; Atkinson R; Skuza EM; Clark M; Gunn AJ; Kirkpatrick CM; Hunt RW; Berger PJ; Nold-Petry CA; Nold MF
Front Immunol; 2022; 13():1022104. PubMed ID: 36389766
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
